The launch of Lilly's oral GLP-1 pill called orforglipron is expected to expand the addressable market
Based on the ingredients, however, it is likely that the most common side effects may include nausea, diarrhoea, vomiting and headaches
Most patients notice reduced appetite and increased satiety within 2-3 weeks of starting injections, with measurable weight loss appearing by week 4-6
10.1155/2020/2596082 17 ArafaH
Ishijima T, Nakajima K (2021) Inflammatory cytokines TNF, IL-1, and IL-6 are induced in endotoxin-stimulated microglia through different signaling cascades
Lack of results after 8 weeks warrants evaluation for inadequate dosing, medication-drug interactions, underlying metabolic conditions, or insufficient caloric deficit despite appetite suppression